European Journal of Neurology

Calendar
pp. i-i(1)

Instructions for Authors
pp. ii-iii(2)

Eye of the Tiger sign in multiple system atrophy
pp. e1-e2(2)
Authors: Strecker, K.; Hesse, S.; Wegner, F.; Sabri, O.; Schwarz, J.; Schneider, J.-P.

Infantile presentation of the mitochondrial A8344G mutation
pp. e3-e5(3)
Authors: Scalais, E.; Nuttin, C.; Seneca, S.; Smet, J.; De Paepe, B.; Martin, J.-J.; Stevens, R.; Pierart, F.; Battisti, O.; Lissens, W.; De Meirleir, L.; Van Coster, R.

The G2019S LRRK2 mutation is uncommon amongst Greek patients with familial Parkinson's disease
pp. e6-e6(1)
Authors: Papapetropoulos, S.; Argyriou, A. A.; Mitsi, G.; Chroni, E.

Abdominal pain associated with musical hallucinations: a case report
pp. e7-e8(2)
Authors: Gentile, S.; Ferrero, M.; Giudice, R. L.; Rainero, I.; Pinessi, L.

Pipette pusher's paresthesia
pp. e9-e9(1)
Authors: Vergouwen, M. D. I.; Vermeulen, M.

Charcot-Marie-Tooth disease type 1A associated with acute porphyric neuropathy
pp. e10-e11(2)
Authors: Jacob, S.; Damian, M. S.; Rajabally, Y. A.

Triple E syndrome
pp. e12-e13(2)
Authors: Belvís, R.; Marlet, V.; Sanuy, B.; Robert, J.; Pagonabarraga, J.; Torrens, C.; Kulisevsky, J.

Brachial plexopathy following a generalized tonic-clonic seizure
pp. e14-e14(1)
Authors: Fernández-Torre, J. L.; Vázquez, J. L.; Leno, C.

Guillain-Barré-like syndrome heralding small-cell lung cancer
pp. e15-e16(2)
Authors: Eimil, M.; Benito-León, J.

Kynurenines in the Brain, from Experiments to Clinics
pp. e17-e17(1)
Author: Jellinger, K.A.

Sleep and Psychosomatic Medicine
pp. e18-e18(1)
Author: Jellinger, K. A.

Neurological Case Histories: Case Histories in Acute Neurology and the Neurology of General Medicine
pp. e19-e19(1)
Author: Jellinger, K. A.

Oxford Handbook of Neurology
pp. e20-e20(1)
Author: Jellinger, K. A.

Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke)
pp. 1189-1200(12)
Authors: Jennum, P.; Santamaria, J.

Role of angiotensin receptor blockers in the prevention and management of ischaemic stroke
pp. 1201-1209(9)
Authors: Mathur, G.; Cleland, J. G. F.; Rodrigues, E.; Davis, G. K.

Relationship between the extent of T2 lesions and the onset of secondary progression in multiple sclerosis
pp. 1210-1215(6)
Authors: Mostert, J. P.; de Groot, J. C.; Ramsaransing, G. S. M.; Koch, M. W.; De Keyser, J.

Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis
pp. 1216-1221(6)
Authors: Paavilainen, T.; Kurki, T.; Parkkola, R.; Färkkilä, M.; Salonen, O.; Dastidar, P.; Elovaara, I.; Airas, L.

Subcortical ischaemic changes in young hypertensive patients: frequency, effect on cognitive performance and relationship with markers of endothelial and haemostatic activation
pp. 1222-1229(8)
Authors: Consoli, D.; Carlo, A. Di; Inzitari, D.; Lucia, D. De; Lamassa, M.; D'Avino, M.; Baldereschi, M.; Muto, M.; Mandarino, A.; Napolitano, M.; Romano, M. F.; Caruso, D.

Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders
pp. 1230-1235(6)
Authors: Takamori, M.; Motomura, M.; Fukudome, T.; Yoshikawa, H.

Catathrenia (nocturnal groaning): an abnormal respiratory pattern during sleep
pp. 1236-1243(8)
Authors: Vetrugno, R.; Lugaresi, E.; Plazzi, G.; Provini, F.; D'Angelo, R.; Montagna, P.

Abnormal surface EMG during clinically normal wrist movement in cervical dystonia
pp. 1244-1250(7)
Authors: de Vries, P. M.; Leenders, K. L.; van der Hoeven, J. H.; de Jong, B. M.; Kuiper, A. J.; Maurits, N. M.

Acute onset of fatal vegetative symptoms: unusual presentation of adult Alexander disease
pp. 1251-1255(5)
Authors: Huttner, H. B.; Richter, G.; Hildebrandt, M.; Blümcke, I.; Fritscher, T.; Brück, W.; Gärtner, J.; Seifert, F.; Staykov, D.; Hilz, M.-J.; Schwab, S.; Bardutzky, J.

Effectiveness of a community-based 3-year advisory program after acquired brain injury
pp. 1256-1265(10)
Authors: Grill, E.; Ewert, T.; Lipp, B.; Mansmann, U.; Stucki, G.

A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate
pp. 1266-1274(9)
Authors: Debouverie, M.; Moreau, T.; Lebrun, C.; Heinzlef, O.; Brudon, F.; Msihid, J.

Low RLS prevalence and awareness in central Greece: an epidemiological survey
pp. 1275-1280(6)
Authors: Hadjigeorgiou, G. M.; Stefanidis, I.; Dardiotis, E.; Aggellakis, K.; Sakkas, G. K.; Xiromerisiou, G.; Konitsiotis, S.; Paterakis, K.; Poultsidi, A.; Tsimourtou, V.; Ralli, S.; Gourgoulianis, K.; Zintzaras, E.

Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up
pp. 1281-1287(7)
Authors: Buttinelli, C.; Clemenzi, A.; Borriello, G.; Denaro, F.; Pozzilli, C.; Fieschi, C.

A novel compound heterozygous dysferlin mutation in Miyoshi myopathy siblings responding to dantrolene
pp. 1288-1291(4)
Authors: Hattori, H.; Nagata, E.; Oya, Y.; Takahashi, T.; Aoki, M.; Ito, D.; Suzuki, N.

The role of MRI of the brain and spinal cord, and CSF examination for the diagnosis of primary progressive multiple sclerosis
pp. 1292-1295(4)
Authors: Nilsson, P.; Sandberg-Wollheim, M.; Norrving, B.; Larsson, E.-M.

Cerebral venous thrombosis caused by spontaneous intracranial hypotension: two cases
pp. 1296-1298(3)
Authors: Richard, S.; Kremer, S.; Lacour, J.-C.; Vespignani, H.; Boyer, P.; Ducrocq, X.

Deep gray matter hyperperfusion with occipital hypoperfusion in dementia with Lewy bodies
pp. 1299-1301(3)
Authors: Sato, T.; Hanyu, H.; Hirao, K.; Shimizu, S.; Kanetaka, H.; Iwamoto, T.

No support for a truncated interferon-α17 allele as risk factor for MS
pp. 1302-1304(3)
Authors: Nyström, M.; Ruuth, K.; Lundgren, E.; Sundström, P.